Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    9624195 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients
Condition: Kidney Trasplant
Intervention: Drug: Valganciclovir

Indicates status has not been verified in more than two years